Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2025-12-26 @ 2:41 AM
Study NCT ID:
NCT01603602
Status:
COMPLETED
Last Update Posted:
2018-08-14
First Post:
2012-05-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
BOTOX® Treatment in Pediatric Upper Limb Spasticity
Sponsor:
Allergan
Organization:
Study Overview
Official Title:
BOTOX® Treatment in Pediatric Upper Limb Spasticity: Double-blind Study
Status:
COMPLETED
Status Verified Date:
2018-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) in pediatric patients with upper limb spasticity.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2012-000062-38 | EUDRACT_NUMBER | None | View |